Search results
Results from the WOW.Com Content Network
ICD 10 code for Arthropathic psoriasis, unspecified. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code L40.50.
L40.52 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM L40.52 became effective on October 1, 2023. This is the American ICD-10-CM version of L40.52 - other international versions of ICD-10 L40.52 may differ.
L40.50 is a billable diagnosis code used to specify arthropathic psoriasis, unspecified. Synonyms: iritis with psoriatic arthritis, oligoarticular joint involvement,
Chapter 12 - Diseases of the skin and subcutaneous tissue (L00-L99) » Papulosquamous disorders (L40-L45) » Psoriatic arthritis mutilans (L40.52)
A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27 -associated SPONDYLARTHROPATHY , and the absence of rheumatoid factor.
Arthropathic psoriasis. L40.5 is a "category code," which means it's non-billable. Billable codes require more specificity.
L40.50 - Arthropathic psoriasis, unspecified. The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products: Find-A-Code Essentials. Find-A-Code Professional.
A form of arthritis associated with psoriasis, psoriatic arthritis can be documented using the latest ICD-10 Codes found under psoriasis section.
Psoriasis, unspecified. 2016 2017 2018 2019 2020 2021 2022 2023 2024 Billable/Specific Code. L40.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM L40.9 became effective on October 1, 2023.
INDICATIONS1. Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Psoriatic Arthritis: SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults.